Gene · 9536
Papers2,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inflammatory Response of THP1 and U937 Cells: The RNAseq Approach. | Cells | 2024 | 39768153 | PubTator, text mining | PubMed |
| Novel Benzimidazole Derivatives as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase 1 for the Potential Treatment of Inflammation, Pain, and Fever. | J Med Chem | 2024 | 39622054 | PubTator, text mining | PubMed |
| Uses of Molecular Docking Simulations in Elucidating Synergistic, Additive, and/or Multi-Target (SAM) Effects of Herbal Medicines. | Molecules | 2024 | 39598795 | PubTator, text mining | PubMed |
| Microsomal Prostaglandin E Synthase-1 Controls Colonic Prostaglandin E2 Production and Exerts a Protective Effect on Colitis Induced by Trinitrobenzene Sulfonic Acid in Mice. | Int J Mol Sci | 2024 | 39596393 | PubTator, text mining | PubMed |
| Roburic acid inhibits lung cancer metastasis and triggers autophagy as verified by network pharmacology, molecular docking techniques and experiments. | Front Oncol | 2024 | 39450260 | PubTator, text mining | PubMed |
| Novel Synthesized Benzophenone Thiazole Hybrids Exhibited Ex Vivo and In Silico Anti-Inflammatory Activity. | Chem Biol Drug Des | 2024 | 39424371 | PubTator, text mining | PubMed |
| PTGES is involved in myofibroblast differentiation via HIF-1α-dependent glycolysis pathway. | J Cell Mol Med | 2024 | 39417702 | PubTator, text mining | PubMed |
| Roles of Toll-like Receptor Signaling in Inflammatory Bone Resorption. | Biology (Basel) | 2024 | 39336119 | PubTator, text mining | PubMed |
| Pivotal roles for cancer cell-intrinsic mPGES-1 and autocrine EP4 signaling in suppressing antitumor immunity. | JCI Insight | 2024 | 39298269 | PubTator, text mining | PubMed |
| A graph self-supervised residual learning framework for domain identification and data integration of spatial transcriptomics. | Commun Biol | 2024 | 39266614 | PubTator, text mining | PubMed |
| In Vitro Bioassay for Damage-Associated Molecular Patterns Arising from Injured Oral Cells. | Bioengineering (Basel) | 2024 | 39061769 | PubTator, text mining | PubMed |
| Efficacy and mechanism of the Ermiao San series of formulas for rheumatoid arthritis based on Chinmedomics strategy. | Phytomedicine | 2024 | 39047412 | PubTator, text mining | PubMed |
| Activation of the PGE2-EP2 pathway as a potential drug target for treating eosinophilic rhinosinusitis. | Front Immunol | 2024 | 39015572 | PubTator, text mining | PubMed |
| Attenuation of adjuvant-induced arthritis with carnosic acid by inhibiting mPGES-1, COX-2, and bone loss in male SD rats. | Immunopharmacol Immunotoxicol | 2024 | 39013842 | PubTator, text mining | PubMed |
| Dexamethasone treatment influences tendon healing through altered resolution and a direct effect on tendon cells. | Sci Rep | 2024 | 38961188 | PubTator, text mining | PubMed |
| In silico exploration of molecular mechanisms for inhibiting inflammatory responses by 3Н-thiazolo[4,5-b]pyridin-2-one derivatives. | Acta Chim Slov | 2024 | 38919094 | PubTator, text mining | PubMed |
| PGE2 binding to EP2 promotes ureteral stone expulsion by relaxing ureter via the cAMP-PKA pathway. | BMC Urol | 2024 | 38851678 | PubTator, text mining | PubMed |
| Design and synthesis of new dihydropyrimidine/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1/5-LOX inhibition. | Front Chem | 2024 | 38800576 | PubTator, text mining | PubMed |
| Zerumbone exhibits anti-inflammatory effects by suppressing eicosanoid signaling: Evidence from LPS-induced peripheral blood leukocytes. | Prostaglandins Other Lipid Mediat | 2024 | 38761959 | PubTator, text mining | PubMed |
| Association between KRAS and PIK3CA Mutations and Progesterone Resistance in Endometriotic Epithelial Cell Line. | Curr Issues Mol Biol | 2024 | 38666954 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9536/papers?page=6